US Patent 12121516 Pharmaceutical composition comprising selexipag
Patent 12121516 was granted and assigned to Actelion Pharmaceuticals Ltd on October, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 7, 2018
0
Date of Patent
October 22, 2024
0
Patent Applicant
Patent Application Number
16491854
0
Patent Inventor Names
Klaus Hellerbrand
0
Alexandra Schlicker-Spain
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 12121516 Pharmaceutical composition comprising selexipag
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.